Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma
In a paper published today in the Journal of Clinical Oncology, Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.
International spotlight on newborn care
Mater’s strong focus on family-integrated care—involving parents in the care of their babies—was a feature of Professor Helen Liley’s address to the prestigious Boston Children’s Hospital (BCH) 150th Anniversary event held this month.
Mater Research CEO appointed to new National Blood Cancer Taskforce
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.
Latest News

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National...

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve...

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ immunopathology specialist was...

22

Jul

RSV vaccine a step closer

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model...

18

Jul

New score to help navigate improved treatment for follicular lymphoma patients

Mater’s Fertility Services program is helping couples restore their reproductive health, and the results from research are looking positive.

27

Jun

Mater's Fertility Service achieves pregnancies through natural approach

Mater Research held its annual 3-minute thesis (3MT) competition last week showcasing the work of Higher Degree Research students and honours...

18

Jun

Mater researchers present three minute thesis

Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic...

10

Jun

Mater researcher investigates a new therapeutic approach for follicular lymphoma

Professor Helen Liley’s addressed the prestigious Boston Children’s Hospital at their 150th Anniversary this month.

31

May

International spotlight on newborn care

Today at Mater there are approximately 200 clinical trials currently underway across many disciplines including nursing and midwifery, all...

20

May

Celebrating International Clinical Trials day

Mater Research and Mater Mothers' Hospitals representatives participated in the Perinatal Society of Australia and New Zealand Annual Congress...

03

Apr

Improving maternal and newborn health outcomes